These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30809636)
1. Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network Analysis. Bower CW; Fridkin DW; Wolford HM; Slayton RB; Kubes JN; Jacob JT; Ray SM; Fridkin SK Clin Infect Dis; 2020 Jan; 70(1):75-81. PubMed ID: 30809636 [TBL] [Abstract][Full Text] [Related]
2. Spread of Carbapenem-Resistant Enterobacteriaceae Among Illinois Healthcare Facilities: The Role of Patient Sharing. Ray MJ; Lin MY; Weinstein RA; Trick WE Clin Infect Dis; 2016 Oct; 63(7):889-93. PubMed ID: 27486116 [TBL] [Abstract][Full Text] [Related]
3. The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities. Toth DJA; Khader K; Slayton RB; Kallen AJ; Gundlapalli AV; O'Hagan JJ; Fiore AE; Rubin MA; Jernigan JA; Samore MH Clin Infect Dis; 2017 Aug; 65(4):581-587. PubMed ID: 28472233 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017. Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland. Lin G; Tseng KK; Gatalo O; Martinez DA; Hinson JS; Milstone AM; Levin S; Klein E; Infect Control Hosp Epidemiol; 2022 Sep; 43(9):1162-1170. PubMed ID: 34674791 [TBL] [Abstract][Full Text] [Related]
6. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Pang F; Jia XQ; Zhao QG; Zhang Y Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291 [TBL] [Abstract][Full Text] [Related]
7. Regional transmission patterns of carbapenemase-producing Enterobacterales: A healthcare network analysis. Tadese BK; Fujimoto K; DeSantis SM; Mgbere O; Darkoh C Infect Control Hosp Epidemiol; 2023 Mar; 44(3):453-459. PubMed ID: 35450553 [TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A; Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106 [TBL] [Abstract][Full Text] [Related]
9. Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia. Reuben J; Donegan N; Wortmann G; DeBiasi R; Song X; Kumar P; McFadden M; Clagon S; Mirdamadi J; White D; Harris JE; Browne A; Hooker J; Yochelson M; Walker M; Little G; Jernigan G; Hansen K; Dockery B; Sinatro B; Blaylock M; Harmon K; Iyengar P; Wagner T; Nelson JA; Infect Control Hosp Epidemiol; 2017 Aug; 38(8):921-929. PubMed ID: 28615088 [TBL] [Abstract][Full Text] [Related]
10. How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling Study. Lee BY; Bartsch SM; Lin MY; Asti L; Welling J; Mueller LE; Leonard J; Brown ST; Doshi K; Kemble SK; Mitgang EA; Weinstein RA; Trick WE; Hayden MK Am J Epidemiol; 2021 Feb; 190(3):448-458. PubMed ID: 33145594 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry. Jimenez A; Trepka MJ; Munoz-Price LS; Pekovic V; Ibrahimou B; Abbo LM; Martinez O; Sposato K; dePascale D; Perez-Cardona A; McElheny CL; Bachman WC; Fowler EL; Doi Y; Fennie K Am J Infect Control; 2020 Nov; 48(11):1341-1347. PubMed ID: 32334004 [TBL] [Abstract][Full Text] [Related]
12. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408 [TBL] [Abstract][Full Text] [Related]
13. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities. Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ; Clin Infect Dis; 2019 Mar; 68(6):964-971. PubMed ID: 29986007 [TBL] [Abstract][Full Text] [Related]
14. Vital signs: carbapenem-resistant Enterobacteriaceae. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2013 Mar; 62(9):165-70. PubMed ID: 23466435 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China. Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797 [TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates. Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease. Tran DM; Larsson M; Olson L; Hoang NTB; Le NK; Khu DTK; Nguyen HD; Vu TV; Trinh TH; Le TQ; Phan PTT; Nguyen BG; Pham NH; Mai BH; Nguyen TV; Nguyen PTK; Le ND; Huynh TM; Anh Thu LT; Thanh TC; Berglund B; Nilsson LE; Bornefall E; Song LH; Hanberger H J Infect; 2019 Aug; 79(2):115-122. PubMed ID: 31125639 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore. Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT; Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792 [TBL] [Abstract][Full Text] [Related]
19. How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region. Lee BY; Bartsch SM; Hayden MK; Welling J; DePasse JV; Kemble SK; Leonard J; Weinstein RA; Mueller LE; Doshi K; Brown ST; Trick WE; Lin MY Clin Infect Dis; 2020 Feb; 70(5):843-849. PubMed ID: 31070719 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Livorsi DJ; Chorazy ML; Schweizer ML; Balkenende EC; Blevins AE; Nair R; Samore MH; Nelson RE; Khader K; Perencevich EN Antimicrob Resist Infect Control; 2018; 7():55. PubMed ID: 29719718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]